Endurance
Engineered for maximum wear time.
Confidence
Never lose a device.
Freedom
Skin Grip moves with you, never against you.
SHOP BESTSELLERS
Skin Grip Original - Dexcom G6 Patches
Choose your option
Skin Grip MAX Dexcom G6 Patches - 10 Pack
Choose your option
Skin Grip Original - Medtronic Guardian/Enlite Adhesive Patches
Choose your option
Skin Grip Original - Freestyle Libre 2+ & Lingo Adhesive Patches
Choose your option
Skin Grip MAX Dexcom G7 & Stelo Patches - 10 Pack
Choose your option
Skin Grip Original - Dexcom G7 & Stelo Adhesive Patches (With Cutout)
Choose your option
Skin Grip Original - Omnipod Adhesive Patches
Choose your option
Skin Grip Original - Dexcom G7 & Stelo Adhesive Patches
Choose your option
Skin Grip - Tandem Mobi Pocket Patch
Choose your option
Sensors Saved
Trusted By
Say Goodbye To
Sensor Failure Mid-Routine
Adhesion built to last through motion, sweat, and time.
Manufacturer Replacements on Repeat
Designed for reliability — not replacements.
Waiting on New Sensors to Arrive
Every patch extends your wear. Every day counts.
Losing a Reading When Life Gets Close
Holds steady through hugs, heat, and high impact.
Returning to Fingerpricks and Frustration
Performance that stays put. Confidence that stays on.
→ Built to grip. Made to stay.
DIABETES MANAGEMENT
Your go-to hub for tips, tricks, and real talk on living boldly with diabetes
How to Prep for an Endo Appointment (So You Actually Get What You Need)
Endocrinology appointments can bring a surprising amount of pressure. Weeks or months of diabetes management often get condensed into a short visit, and it’s easy to walk in already feeling behind. There’s the upload of device data, the anticipation of hearing feedback about your numbers, and the quiet stress of trying to remember every frustration you meant to bring up once the appointment actually starts. A lot of people leave these visits realizing they spent most of the time reacting instead of communicating what they actually needed. A little preparation ahead of time can help shift the appointment from a rushed data review into a more useful conversation about how diabetes is actually fitting into your life. Your Data Only Tells Part of the Story Most endo appointments begin with numbers. Time in range, averages, trends, and alerts tend to shape the conversation quickly. While those metrics matter, they rarely tell the full story of what daily life with diabetes feels like. Poor sleep, burnout, constant alarms, exercise anxiety, work stress, and frustration with devices may not show up clearly in a graph, even though they affect management constantly. Going into your appointment with a sense of what has felt difficult lately can help create a more meaningful discussion. Sometimes the most important thing to talk about has nothing to do with a percentage. Think About What’s Actually Frustrating You Before your visit, it helps to spend a few minutes reflecting on what’s been bothering you most day to day. Maybe your CGM keeps peeling off early during workouts. Maybe your current pump setup feels inconvenient during long work shifts. Maybe you’re exhausted by overnight alarms or finding yourself ignoring notifications entirely. These are important details to bring up. Diabetes management is not just about achieving target numbers. It’s also about building routines and systems that feel sustainable in real life. Don’t Rely on Memory During the Appointment One of the easiest ways to prepare is to keep a running note in your phone in the weeks leading up to the visit. Questions tend to disappear the second the appointment starts. Writing things down ahead of time creates space to focus on the conversation instead of trying to remember every concern at once. That note might include: Prescription refill needs Questions about newer technology Patterns you’ve noticed Lifestyle changes Burnout or stress Even a short list can help the appointment feel more productive. Be Honest About What Diabetes Looks Like Right Now There can be pressure to present a more polished version of diabetes management during appointments. Many people instinctively downplay the harder parts or avoid talking about habits they feel frustrated by. In reality, diabetes routines are rarely perfect. Alarms get ignored. Carb counting becomes more approximate than exact. Devices can feel exhausting to wear all the time. Life gets busy. Conversations tend to become much more helpful when they reflect what’s actually happening instead of what feels ideal on paper. Use the Appointment to Talk About Technology Diabetes technology is evolving quickly, and endo visits can be a good time to revisit whether your current setup still fits your life. That might mean discussing: Different pump or CGM options Alert fatigue Adhesion struggles Exercise-related frustrations Interest in automated insulin delivery systems Simplifying your current routine A device does not have to be completely failing before it’s worth exploring alternatives. Burnout Belongs in the Conversation Too Not every diabetes challenge is a settings issue. Sometimes the biggest issue is simply the mental weight of managing diabetes every day. The constant attention, decision-making, and interruptions can wear people down over time, especially when life is already stressful. Bringing up burnout during an appointment is completely reasonable. Support might look like adjusting routines, simplifying parts of your setup, connecting with a CDCES, or finding ways to reduce some of the mental load. Those conversations are just as important as reviewing glucose data. The Best Appointments Feel Collaborative The most productive endo appointments often feel less like a performance review and more like a collaboration. Your provider brings clinical expertise, but you bring something equally important: the lived experience of managing diabetes every day. You know what feels sustainable, what causes stress, and what routines realistically fit into your life. A successful appointment is not defined by perfect numbers. It’s leaving with clearer support, better tools, and a plan that feels realistic for the life you’re actually living.
Read more
AI Is Quietly Changing Diabetes Tech – Here’s What That Actually Means
AI is everywhere. Not without some controversy, it shows up in headlines, product launches, and in just about every industry. In diabetes tech, the shift to AI has been subtle in nature yet quietly impactful in improving day-to-day life. This isn’t about fully hands-off systems just yet. It’s about something more immediate: technology that’s starting to take a step ahead, so you don’t have to think through every single decision in real time. It’s Already Happening (Even If It Doesn’t Feel Like It) If you use an automated insulin delivery system, you’ve probably noticed that things feel a little smoother than they used to. That’s not by accident. Modern systems aren’t just responding to your current glucose reading. They’re watching trends, adjusting insulin in the background, and making small changes throughout the day and night. It might not be labeled as AI in big bold letters, but the underlying algorithms are getting more advanced with each update. The result is subtle, but meaningful. There’s often less need to chase highs or react quickly to drops because the system is already working behind the scenes. Prediction Is Getting Better—and Faster One of the biggest shifts happening right now is how early systems can respond. Instead of waiting for a high or low to happen, newer algorithms are getting better at predicting where your glucose is headed and adjusting before you feel the impact. This is where AI plays a bigger role. These systems are processing patterns that would be difficult to track manually, especially over days and weeks of data. Over time, they start to recognize how your body typically responds and use that information to act sooner. What this looks like day to day is fewer surprises. You may still see fluctuations, but they’re often less abrupt and easier to manage. The Pressure to Be “Perfect” Is Starting to Ease For a long time, diabetes tech has relied heavily on precise inputs. Exact carb counts, carefully timed boluses, and constant adjustments have been part of the routine. That expectation is starting to shift. Newer systems are getting better at correcting for missed or imperfect inputs. If a meal estimate is off or a bolus is delayed, the system can often step in and help smooth things out. Some platforms are even moving toward simplified meal inputs instead of requiring exact numbers. It doesn’t remove the need for involvement, but it does take some of the pressure off getting everything exactly right. Apps Are Starting to Act More Like a Co-Pilot AI isn’t just showing up in pumps. It’s also becoming more visible in apps and software that work alongside CGMs. Instead of simply displaying data, these tools are starting to interpret it. They can highlight patterns, flag trends, and in some cases suggest next steps based on what they’re seeing. That means less time staring at graphs and trying to figure out what changed, and more clarity around what’s actually happening. It’s a shift from raw data to something more useful and actionable. Systems Are Beginning to Learn You This might be the most meaningful change of all. Earlier systems depended on settings that you had to dial in and adjust over time. Basal rates, ratios, and correction factors were often static unless you changed them. Now, systems are starting to adapt more dynamically. They learn from your patterns, adjust to your routines, and gradually align more closely with how your body actually behaves. Instead of forcing your day to fit the system, the system is starting to fit your day. That doesn’t mean it’s perfect, but it does mean less constant tweaking. What AI Doesn’t Solve Even with all this progress, there are still limits. Diabetes is complex, and not everything is predictable. Meals, movement, stress, and hormones can all affect glucose in ways that are hard to anticipate. Technology can support you, but it doesn’t replace awareness entirely. There are still moments where you need to step in and make decisions. The Bigger Shift: Less Mental Load The real impact of AI in diabetes tech isn’t about the technology itself. It’s about how it changes the experience of living with diabetes. There are fewer urgent decisions, fewer interruptions, and a growing sense that your system is helping carry some of the weight. You’re still involved, but you’re not doing everything on your own. That shift adds up over time. Final Thoughts AI in diabetes tech isn’t something that’s coming in the future. It’s already here, just in a quieter, more gradual way. It shows up in how your system predicts trends, adjusts insulin, and learns from your data. Each update may feel small, but together they’re moving things in a clear direction. Less effort. More support. More space to focus on the rest of your life.
Read more
Dual-Hormone Systems Are Coming: Insulin + Glucagon Tech to Watch
Most diabetes technology today is built around one main job: delivering insulin. And or many people, automated insulin delivery systems have already made life a lot easier. But there’s still one missing piece. Your body doesn’t just use insulin. It also uses glucagon, a hormone that raises blood sugar when it drops too low. And now, companies are actively working on systems that use both. These are called dual-hormone systems, and they could represent one of the biggest shifts in diabetes tech in years. What Is a Dual-Hormone System? A dual-hormone system is simple in concept: it's designed to deliver both insulin to bring glucose down and glucagon to raise it back up. Instead of relying only on insulin and treating lows with glucose, these systems aim to automatically balance both sides, mimicking how a pancreas works. By delivering small doses of glucagon and insulin, these dual-hormone systems will reduce the need for constant intervention and hyper vigilance. What’s New in This Space Dual-hormone systems have been studied for years, but a few key shifts are moving things forward. More Stable Glucagon One of the biggest barriers has been glucagon stability. Traditional glucagon breaks down quickly once mixed, making it difficult to use in a pump. Newer formulations, like dasiglucagon, are much more stable and designed for continuous use. This has opened the door for real device development. More Advanced Algorithms Modern systems are getting better at coordinating insulin and glucagon delivery. Recent research shows: Improved time in range Fewer hypoglycemic events Better overall glucose stability These systems are learning how to balance both hormones in real time, which is a major step forward. Who’s Actually Building These Systems? This isn’t just theoretical. There are real companies working on this right now. Beta Bionics Beta Bionics is leading the charge with its iLet Bionic Pancreas. The current iLet system is insulin-only The platform is designed to support a dual-hormone version Ongoing trials are testing systems that use insulin + dasiglucagon Beta Bionics has partnered with companies like Xeris to support stable glucagon delivery, which is a key piece of making this work in real life. This is the closest system to becoming widely available in the future. Inreda Diabetic Inreda, based in Europe, has already developed a dual-hormone artificial pancreas system that delivers both insulin and glucagon. It has been used in limited real-world settings It mimics natural pancreatic function more closely than insulin-only systems While not widely available yet, it shows that dual-hormone systems can work outside of research environments. What’s Still Challenging There are still hurdles to overcome: Device complexity (two hormones instead of one) Cost and accessibility Regulatory approval timelines Real-world usability These systems are promising, but not ready for widespread use just yet. What to Expect in the Next 3–5 Years Here’s a realistic look at what’s ahead: Next 1–2 Years Continued clinical trials of dual-hormone systems More data presented at conferences like ATTD and ADA Refinement of glucagon formulations 2–3 Years Expanded real-world testing More companies entering the space Early regulatory conversations 3–5 Years Potential first broader commercial launches More user-friendly system designs Integration with existing CGMs and pump ecosystems Timelines can shift, but the momentum is clearly building. Final Thoughts We’re still early, but this space is moving faster than it has in years. With companies like Beta Bionics pushing forward and real-world systems already being tested, dual-hormone technology is becoming more tangible. It won’t replace everything overnight, but it could significantly decrease the number of decisions required every day, reducing the mental load of living with diabetes.
Read more
